These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 8457627)

  • 21. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
    Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
    Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
    Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
    Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.
    Lefor AT; Fabian DF
    J Surg Res; 1998 Feb; 75(1):49-53. PubMed ID: 9614856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte chemotactic activity of human interleukin 1.
    Miossec P; Yu CL; Ziff M
    J Immunol; 1984 Oct; 133(4):2007-11. PubMed ID: 6332145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes.
    Kagamu H; Shu S
    J Immunol; 1998 Apr; 160(7):3444-52. PubMed ID: 9531305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
    Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
    Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells.
    Van Epps DE; Durant DA; Potter JW
    J Immunol; 1983 Aug; 131(2):697-700. PubMed ID: 6223091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice.
    Benomar A; Ming WJ; Taraboletti G; Ghezzi P; Balotta C; Cianciolo GJ; Snyderman R; Doré JF; Mantovani A
    J Immunol; 1987 Apr; 138(7):2372-9. PubMed ID: 3104464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial characterization of a novel chemotactic factor produced by macrophages.
    Gómez-Flores R; Tamez-Guerra R
    Rev Latinoam Microbiol; 1992; 34(1):67-70. PubMed ID: 1345307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants.
    Wang JM; Cianciolo GJ; Snyderman R; Mantovani A
    J Immunol; 1986 Oct; 137(8):2726-32. PubMed ID: 3760573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The initial characterization of a thymus factor chemotactic to bone marrow cells.
    Taubenberger JK; Haar JL
    Thymus; 1987; 9(2):85-93. PubMed ID: 3296335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotactic activity of porcine insulin for human T lymphocytes in vitro.
    Berman JS; Center DM
    J Immunol; 1987 Apr; 138(7):2100-3. PubMed ID: 3549897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.